drugset / Trial / NCT00005042
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Treatment
Summary
RATIONALE: SU5416 may stop the growth of Kaposi's sarcoma by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have AIDS-related Kaposi's sarcoma.
Timeline
- Start
- 2000-01
- Primary completion
- 2000-11
- Completion
- 2000-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | semaxanib | Small molecule | — | Intravenous |